Analystreport

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its "hold" rating re-affirmed by analysts at TD Cowen. They now have a $47.00 price target on the stock, down previously from $66.00.

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report